45
Views
5
CrossRef citations to date
0
Altmetric
Research Article

In Vivo Effects of Recombinant-Interferon-β1b Treatment on Polymorphonuclear Cell and Monocyte Functions and On T-Cell-Mediated Antibacterial Activity in Patients with Relapsing-Remitting Multiple Sclerosis

, , , , , , , & show all
Pages 1-18 | Published online: 27 Sep 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Jarred Napier, Lucas Rose, Opeolu Adeoye, Edmond Hooker & Kyle B. Walsh. (2019) Modulating acute neuroinflammation in intracerebral hemorrhage: the potential promise of currently approved medications for multiple sclerosis. Immunopharmacology and Immunotoxicology 41:1, pages 7-15.
Read now
R Calvello, M Saccia, A. B Maffione, M. A Panaro & V Mitolo. (2002) POWER SPECTRAL ANALYSIS OF THE SHAPE OF fMLP-STIMULATED GRANULOCYTES. A TOOL FOR THE STUDY OF CYTOSKELETAL ORGANIZATION UNDER NORMAL AND PATHOLOGICAL CONDITIONS. Immunopharmacology and Immunotoxicology 24:1, pages 139-163.
Read now

Articles from other publishers (3)

Sara Scutera, Tiziana Musso, Paola Cavalla, Giorgia Piersigilli, Rosaria Sparti, Sara Comini, Marco Vercellino, Anna Maria Cuffini, Giuliana Banche & Valeria Allizond. (2020) Inhibition of Human Neutrophil Functions In Vitro by Multiple Sclerosis Disease-Modifying Therapies. Journal of Clinical Medicine 9:11, pages 3542.
Crossref
Alexander Winkelmann, Micha Loebermann, Emil C. Reisinger, Hans-Peter Hartung & Uwe K. Zettl. (2016) Disease-modifying therapies and infectious risks in multiple sclerosis. Nature Reviews Neurology 12:4, pages 217-233.
Crossref
Marco Cardone, Kyojiro N Ikeda, Barbara Varano, Filippo Belardelli, Enrico Millefiorini, Sandra Gessani & Lucia Conti. (2014) Opposite regulatory effects of IFN-β and IL-3 on C-type lectin receptors, antigen uptake, and phagocytosis in human macrophages. Journal of Leukocyte Biology 95:1, pages 161-168.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.